[Circulating Tumor DNA Analysis in Lymphomas].

Abstract excerpt

In recent years, sequencing of circulating tumor DNA(ctDNA)in peripheral blood has emerged as a promising non-invasive approach for diagnosis, genotyping, risk stratification, response monitoring, and the detection of actionable mutations in malignant lymphomas. Current available technologies for ctDNA detection are polymerase chain reaction-based methods and next generation sequencing techniques. They target...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Biomarkers, Tumor
• Share to Circulating Tumor DNA
• Share to High-Throughput Nucleotide Sequencing